Perceptive Advisors’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Perceptive Advisors’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-238	Closed	-$190K	–	124
2018 Q4	$190K	Hold	238	–	–	0.01%	98
2018 Q3	$365K	Buy	+238	New	+$491K	0.01%	110

Other funds holding VCNX

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors's VCNX Position: Q1 2019 in Review

Perceptive Advisors sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2019, closing a stake of 238 shares — an estimated $190K sold.

Perceptive Advisors first reported a position in VCNX in Q3 2018 and held it in 2 quarters. The position peaked at $365K in Q3 2018. 9 funds tracked by Wall St. Rank hold VCNX as of Q1 2019.

Perceptive Advisors reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Perceptive Advisors sold 238 Vaccinex, Inc. Common Stock shares in Q1 2019, an estimated $190K.
Perceptive Advisors first reported a position in Vaccinex, Inc. Common Stock in Q3 2018 and held it in 2 quarters.
Perceptive Advisors's Vaccinex, Inc. Common Stock position peaked at $365K in Q3 2018.
9 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2019.

Based on Perceptive Advisors's 13F filing for Q1 2019, filed 15 May 2019.